as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹15.23
Change
+0.48 (3.25%)
Open
₹14.5
Prev. Close
₹14.75
Day High
₹15.24
Day Low
₹14.5
Volume Analysis
Traded
2,977
Delivered
1,811
Delivery %
60.83%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (2)
- •Promoter holding is falling
- •Below-average fundamentals quality score (33/100)
Opportunities (1)
- •FII holding has been rising
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹16.22 | ₹15.73 | ₹15.48 | ₹14.99 | ₹14.74 | ₹14.25 | ₹14.0 |
| Fibonacci | ₹15.73 | ₹15.45 | ₹15.27 | ₹14.99 | ₹14.71 | ₹14.53 | ₹14.25 |
| Camarilla | ₹15.43 | ₹15.37 | ₹15.3 | ₹14.99 | ₹15.16 | ₹15.09 | ₹15.03 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
+10.36%
1 Week
-0.85%
1 Month
+2.01%
3 Months
-13.17%
6 Months
+7.03%
1 Year
+33.6%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Company Overview
Sector
Healthcare
Market Cap
₹12 Cr
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 26 Sep 2026. Not investment advice.
TopFund Analysis
Ortin Global Limited scores weakly on TopFund's composite fundamentals check within the Healthcare sector, at 33/100. The strongest factor is Risk & Volatility (66/100), while Valuation (0/100) is the weakest area to weigh before deciding. Notably: Promoter holding is falling; below-average fundamentals quality score (33/100). FII holding has been rising.
TopFund Score — Fundamentals Quality
33/100 — WeakData confidence: 60/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Valuation
Corporate Governance
Momentum
Institutional Ownership
Risk & Volatility
Liquidity
From Screener.in
- −Promoter holding is low: 1.23%
- −Promoter holding has decreased over last 3 years: -6.13%
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
AGM on 30 Sep 2026; board approved director role changes and Parveen Satija appointment effective 7 Sep 2026.
Prakruti Prashant Sawant resigns as Whole-time Director effective 07.09.2026.
Board approved MD change, WTD resignation/appointment, and AGM on 30 Sep 2026.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2011 | Mar 2012 | Jun 2012 | |
|---|---|---|---|
| Sales + | 20 | 20 | 16 |
| Expenses + | 17 | 21 | 14 |
| Operating Profit | 3 | -1 | 2 |
| OPM % | 13.53% | -5.06% | 13.06% |
| Other Income + | 0 | 0 | 0 |
| Interest | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 0 |
| Profit before tax | 2 | -2 | 1 |
| Tax % | 33.33% | -11.93% | 33.33% |
| Net Profit + | 1 | -2 | 0 |
| EPS in Rs | 3 | -1 | 0 |
| Raw PDF | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 92.64% | 92.64% | 98.76% | 92.53% | 92.52% | 92.52% | 92.24% | 92.24% | 97.08% | 97.09% | 97.1% | 96.96% |
| Promoters | 7.37% | 7.36% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% |
| FII | 0.0% | 0.0% | 0.0% | 6.25% | 6.25% | 6.25% | 6.53% | 6.53% | 1.68% | 1.68% | 1.68% | 1.8% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Ortin Global Limited (this stock) | 12 | — | — | — |
| Medi Caps Ltd. | 31 | — | 0.28 | -9.21% |
| Gkb Ophthalmics Ltd. | 36 | 9.69 | 0.66 | 3.28% |
| Vivo Bio Tech Ltd. | 38 | — | 0.4 | -2.0% |
| Vivimed Labs Limited | 46 | — | -0.22 | — |
| Mangalam Drug & Chem Ltd | 50 | — | 0.49 | -35.2% |
| Sunil Healthcare Ltd. | 78 | 21.1 | 1.12 | 6.01% |
Which Mutual Funds Hold Ortin Global Limited?
Frequently Asked Questions about Ortin Global Limited
Ortin Global Limited (ORTINGLOBE) closed at ₹15.23 on NSE on 25 September 2026, up 0.48 (3.25%) from the previous close.
Ortin Global Limited trades on the NSE (National Stock Exchange of India) under the symbol ORTINGLOBE.
Ortin Global Limited has a dividend yield of 0.0%.
Ortin Global Limited's 52-week high is ₹21.3 and its 52-week low is ₹10.7.
Ortin Global Limited has a market capitalisation of ₹12 crore.
Ortin Global Limited has a TopFund Quality Score of 33/100 (Weak), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Ortin Global Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.